Related Experiment Video

Updated: May 17, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Congestive heart failure and diabetes mellitus: balancing glycemic control with heart failure improvement

Saifullah Nasir1, David Aguilar

  • 1Winters Center for Heart Failure Research, and Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA. daguilar@bcm.edu

The American Journal of Cardiology
|October 16, 2012
PubMed

Insights

Managing diabetes mellitus (DM) in patients with heart failure (HF) requires careful consideration of HF medications

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Coexistence of diabetes mellitus (DM) and heart failure (HF) is common and associated with worse patient outcomes.
  • Individualized glycemic control is recommended, particularly in patients with comorbid DM and HF.
  • Understanding medication interactions is crucial for effective management.

Purpose of the Study:

  • To review the influence of heart failure medications on glycemic control.
  • To examine the benefits and challenges of common glycemic medications in HF patients.
  • To discuss optimal glycemic targets in patients with DM and HF.

Main Methods:

  • Literature review of studies investigating the interplay between DM, HF, and their treatments.
  • Analysis of data on glycemic control effects of HF pharmacotherapies.
  • Evaluation of glycemic agents' efficacy and safety in HF populations.

Main Results:

  • Proven pharmacologic HF therapies offer clinical benefits to patients with DM and HF, despite potential modest effects on glycemic control.
  • Commonly used glycemic medications present both benefits and challenges in the context of HF.
  • Current data and controversies highlight the need for defined optimal glycemic targets.

Conclusions:

  • Clinical benefits of HF therapies outweigh potential glycemic alterations in patients with DM and HF.
  • Careful selection of glycemic medications is necessary to manage risks and optimize outcomes.
  • Further research is essential to establish optimal glycemic targets for this complex patient group.

More Related Videos

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.